GGrantIndex
Sort

261,768 grants matching gene therapy

Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation

$2,343,563
Munira Basrai · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Human anti-viral immune responses in tissues and circulation

$2,343,548
Donna L Farber · Columbia University Health Sciences · U19 · FY2022 · AI

Human anti-viral immune responses in tissues and circulation

$2,343,548
Donna L Farber · Columbia University Health Sciences · U19 · FY2024 · AI

Human anti-viral immune responses in tissues and circulation

$2,343,548
Donna L Farber · Columbia University Health Sciences · U19 · FY2023 · AI

Human anti-viral immune responses in tissues and circulation

$2,343,548
Donna L Farber · Columbia University Health Sciences · U19 · FY2025 · AI

Characterization of the Osteosarcoma Genome

$2,343,330
Paul S. Meltzer · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Immunometabolism in Cancer and Inflammation

$2,343,076
Daniel W. McVicar · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Genetic approaches to discover host factors critical to dengue virus infection

$2,342,634
Jan E Carette · Stanford University · DP2 · FY2012 · AI

Molecular Genetics of Endocrine Tumors and Related Disorders

$2,342,543
Constantine A. Stratakis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD

CANCER CENTER SUPPORT GRANT

$2,342,171
Theodore G Krontiris · Beckman Research Institute/City Of Hope · P30 · FY2006 · CA

Pharmacogenomics of Anti-platlet Intervention-2 (PAPI-2) Study

$2,341,982
Alan R. Shuldiner · University Of Maryland Baltimore · U01 · FY2010 · HL

Genetics, Pathophysiology, and Treatment of Recessive Autoinflammatory Diseases

$2,341,702
Daniel Kastner · National Human Genome Research Institute · ZIA · FY2022 · HG

Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer

$2,341,652
Roy S Herbst · Yale University · P50 · FY2025 · CA

UCSF PROSTATE CANCER SPORE

$2,341,539
University Of California San Francisco · P50 · FY2000 · CA

Advancing Transplantation Outcomes in Children

$2,341,354
David Michael Briscoe · Boston Children'S Hospital · U01 · FY2021 · AI

Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma

$2,341,318
Reynold Alexander Panettieri · University Of Pennsylvania · P01 · FY2014 · HL

Pharmaceutical Research Center

$2,340,897
Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · G12 · FY2011 · RR

Pharmaceutical Research Center

$2,340,738
Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · G12 · FY2012 · MD

Combining Physiological, Genetic, and Computational Approaches with Naturalistic Climbing Behavior to Elucidate the Functional Elements of Descending Motor Control

$2,340,462
Joseph Andrew Miri · Northwestern University · DP2 · FY2020 · NS

Cure Sickle Cell

$2,340,191
Mary Eapen · Medical College Of Wisconsin · OT3 · FY2023 · HL

Knockin mouse models of Alzheimer's Disease

$2,340,048
Hui Zheng · Baylor College Of Medicine · RF1 · FY2022 · AG

Direct Epigenetic Reprogramming of T Cells

$2,340,000
Artem Barski · Cincinnati Childrens Hosp Med Ctr · DP2 · FY2015 · GM

New approaches for understanding lipid movement in health and disease

$2,339,780
Stephen G Young · University Of California Los Angeles · P01 · FY2019 · HL

Translational development of new agents alone and in combination to combat Gram-negative pathogens important in Ventilator- Associated Bacterial Pneumonia: Leveraging the Gram-negative toolbox that is

$2,339,559
Arnold Louie · University Of Florida · P01 · FY2025 · AI

The Lung Endothelium as an Instructive Niche for the Innate Immune System during Vascular Injury

$2,339,338
Dolly Mehta · University Of Illinois At Chicago · P01 · FY2022 · HL